Guenthoer J, Garrett M, Lilly M, Depierreux D, Ruiz F, Chi M
PLoS Pathog. 2024; 20(8):e1012383.
PMID: 39093891
PMC: 11324185.
DOI: 10.1371/journal.ppat.1012383.
Lee R, Cheng S, Zhao J, Tsoi A, Lau K, Chan C
Influenza Other Respir Viruses. 2024; 18(5):e13309.
PMID: 38725111
PMC: 11082085.
DOI: 10.1111/irv.13309.
Mishra J, Mishra P, Arora N
Environ Sustain (Singap). 2024; 4(3):455-467.
PMID: 38624661
PMC: 8005368.
DOI: 10.1007/s42398-021-00165-x.
Lidenge S, Yalcin D, Bennett S, Ngalamika O, Kweyamba B, Mwita C
Viruses. 2024; 16(3).
PMID: 38543814
PMC: 10975915.
DOI: 10.3390/v16030448.
Outteridge M, Nunn C, Devine K, Patel B, McLean G
Viruses. 2024; 16(1).
PMID: 38275966
PMC: 10820748.
DOI: 10.3390/v16010156.
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection.
Sobhani K, Cheng S, Binder R, Mantis N, Crawford J, Okoye N
Vaccines (Basel). 2023; 11(11).
PMID: 38005976
PMC: 10674881.
DOI: 10.3390/vaccines11111644.
SARS-CoV-2 and the DNA damage response.
Grand R
J Gen Virol. 2023; 104(11).
PMID: 37948194
PMC: 10768691.
DOI: 10.1099/jgv.0.001918.
Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity.
Bansal S, Fleming T, Canez J, Maine G, Bharat A, Walia R
Transpl Immunol. 2023; 81:101940.
PMID: 37866672
PMC: 11019873.
DOI: 10.1016/j.trim.2023.101940.
A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019.
Apostolo D, Ferreira L, Di Tizio A, Ruaro B, Patrucco F, Bellan M
Microorganisms. 2023; 11(8).
PMID: 37630598
PMC: 10459962.
DOI: 10.3390/microorganisms11082038.
Phytochemical Profiling and Antiviral Activity of Green Sustainable Nanoparticles Derived from (Roxb.) Sweet against Human Coronavirus 229E.
Abdelgawad F, El-Hawary S, El-Kader E, Alshehri S, Rabeh M, El-Mosallamy A
Plants (Basel). 2023; 12(15).
PMID: 37570967
PMC: 10420985.
DOI: 10.3390/plants12152813.
Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era.
Harrison C, Doster J, Landwehr E, Kumar N, White E, Beachboard D
Microorganisms. 2023; 11(2).
PMID: 36838410
PMC: 9961755.
DOI: 10.3390/microorganisms11020445.
Impact of SARS-CoV-2 on pregnancy outcomes (Review).
Tsikouras P, Kourti V, Gerede A, Kiosse E, Panopoulou M, Zervoudis S
Med Int (Lond). 2023; 1(5):19.
PMID: 36698529
PMC: 9829087.
DOI: 10.3892/mi.2021.19.
Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo.
Lee D, Jo H, Jang Y, Bae S, Agura T, Kang D
Int J Mol Sci. 2023; 24(1).
PMID: 36614125
PMC: 9820929.
DOI: 10.3390/ijms24010678.
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.
Murray S, Ansari A, Frater J, Klenerman P, Dunachie S, Barnes E
Nat Rev Immunol. 2022; 23(5):304-316.
PMID: 36539527
PMC: 9765363.
DOI: 10.1038/s41577-022-00809-x.
Comparative imaging findings among different primary betacoronaviruses.
Sharp W, Jang I, Diaz M, Tou L, Agyemang C, Carter R
Pol J Radiol. 2022; 87:e641-e651.
PMID: 36532251
PMC: 9749786.
DOI: 10.5114/pjr.2022.121763.
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2.
Wali L, Karbiener M, Chou S, Kovtunyk V, Adonyi A, Gosler I
J Virus Erad. 2022; 8(4):100305.
PMID: 36514716
PMC: 9731833.
DOI: 10.1016/j.jve.2022.100305.
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses.
Venkataraman S
Vaccines (Basel). 2022; 10(11).
PMID: 36366313
PMC: 9699630.
DOI: 10.3390/vaccines10111805.
Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction.
Singh R, Kumar A, Rane J, Khan R, Tripathi G, Ajay A
Sci Rep. 2022; 12(1):17038.
PMID: 36220880
PMC: 9552724.
DOI: 10.1038/s41598-022-20759-7.
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?.
Asamoah-Boaheng M, Grunau B, Karim M, Jassem A, Bolster J, Marquez A
Front Immunol. 2022; 13:954093.
PMID: 36159791
PMC: 9493031.
DOI: 10.3389/fimmu.2022.954093.
The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs.
Mekawy A, Alaswad Z, Ibrahim A, Mohamed A, AlOkda A, Elserafy M
J Genet Eng Biotechnol. 2022; 20(1):104.
PMID: 35829826
PMC: 9277982.
DOI: 10.1186/s43141-022-00388-3.